Magnus Andersson

Magnus Andersson's work experience begins in 2004 as a Sales Representative at Wyeth. Magnus then moves on to work at Eisai as a Product Manager from 2006 to 2008. In 2008, Andersson joins Bristol-Myers Squibb, starting as a Medical Science Manager/Disease Area Specialist Immunoscience and progressing through several scientific advisor and senior scientific advisor roles in Oncology and Immunoscience. Andersson then transitions to Takeda in 2018, where they serve as a Medical Advisor for Neuroscience and later for Oncology. Currently, Andersson holds the position of Head of Medical Affairs Nordic at Merz Therapeutics, starting in 2023.

Magnus Andersson completed their MSc in Pharmacy from Uppsala University between 1996 and 2003. Magnus also attended Illinois State University from 2001 to 2002, and The University of Kansas from 1998 to 1999. The degrees and fields of study for their time at Illinois State University and The University of Kansas are not provided.